|
Shcherbakova O.N., Pyko A.A., Safonkina O.S., Kuosa T.A., Likhotkina E.A., Popilov M.A.
Assessment of an integrated approach to the treatment of comorbid pathology using the enterosorption method
|
№1 / 2021
|
|
Syrov A.V., Minushkina L.O.
Choosing the optimal thiazide-like diuretic in patients with arterial hypertension
|
№1 / 2021
|
|
Orlova S.V., Nikitina E.A., Prokopenko E.V., Vodolazkaya A.N.
Iron deficiency management: diet, dietary supplements or drugs?
|
№1 / 2021
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Strategy of mucolytic therapy: ambroxol
|
№1 / 2021
|
|
Karateev A.E.
Chronic musculoskeletal pain as a global therapeutic problem
|
№1 / 2021
|
|
Karateev A.E., Lila A.M., Alekseeva L.I.
Management of patients with diseases of the musculoskeletal system during the COVID-19 pandemic
|
№1 / 2021
|
|
Alekseeva L.I.
Analysis of the latest foreign clinical recommendations for the treatment of osteoarthritis
|
№1 / 2021
|
|
Vertkin A.L., Romasenko L.V., Isaev M.R., Khuzina I.A., Navruzova N.Kh., Kukartseva K.V., Chuprina S.Y., Zozik I.V., Khacheva K.K.
The therapy of anxiety and depressive disorders in patients with arterial hypertension: the results of All-Russian open prospective observational clinical study TEATR
|
№1 / 2021
|
|
Pilipovich A.A., Danilov Al.B
Therapy of various origin pain: new opportunities of diclofenac
|
№4 / 2019
|
|
Golubkina E.V., Levitan B.N., Umerova A.R., Kamneva N.V.
The effectiveness of standard triple anti-helicobacter first line therapy – the experience of the last decade
|
№4 / 2019
|
|
Khripunova A.A., Khripunova I.G., Boeva O.I.
Rosuvastatin as a basis for primary and secondary prevention of cardiovascular diseases and their complications
|
№4 / 2019
|
|
Veselov A.V., Sapozhnikov S.P., Aryasova I.K., Bulavkina M.S., Muratov I.I., Poltorykhina E.A., Romanov R.I., Serbina A.A.
Organizational and clinical aspects of diagnostics and treatment of irritable bowel syndrome
|
№3 / 2019
|
Русский
